Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children 
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Trump Signs Order to Cut Routine Childhood Vaccines 
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough 
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak 
3 clinical-grade skincare creams you really shouldn’t buy online 
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds 
France Keeps Top Health Alert as Officials Brace for Another Heatwave 
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations 
Add as a preferred source on Google
Despite conclusive evidence that it’s one of the most dangerous and addictive substances in the world, sugar is still widely used for a variety of purposes. In an effort to curb the effects of this sweet food, substitutes like aspartame have been introduced. Naturally, there were concerns about its supposed effects on health, but a recent study found that there were no causes for concern.
Recently published in The Journal of Nutrition, researchers basically looked into the effects of aspartame on several factors of health. These included glucose tolerance, weight, and appetite. The results indicated that the sugar substitute basically had no negative impact on any of those factors.
“With the exception of the baseline OGTT glucose concentration at 60 min (and resulting area under the curve value), there were no group differences for glucose, insulin, resting leptin, glucagon-like peptide 1, or gastric inhibitory peptide at baseline or week 12,” the results of the study reads. “There also were no effects of aspartame ingestion on appetite, body weight, or body composition.”
The study lasted for 12 weeks from start to finish, and throughout that period, the subjects were divided into three groups. One group took no aspartame while another took 350 mg per day. The third group took a much higher dosage of 1,050 mg of the sugar substitute.
Blood samples were taken from the subjects before the start of the trial and at the end of the 12-week course. Apparently, the participants did not show any significant differences in the factors that the researchers were looking at. In conclusion, the researchers note that their findings do not support the notion that aspartame comes with negative consequences such as obesity and an increase in rates of hunger.
On the other hand, Medical News Bulletin did note that the study received support from Ajinomoto Co., Inc., which produces products such as artificial sweeteners. However, the authors of the study insist that the findings of their aspartame research were not affected by the source of the funds.
